Myelodysplastic syndromes: what do hospitalists need to know? - Wikidata - awgldk - TriplyDB

Myelodysplastic syndromes: what do hospitalists need to know?

Myelodysplastic syndromes: what do hospitalists need to know?

http://www.wikidata.org/entity/Q27011372

about

Beyond hypomethylating agents failure in patients with myelodysplastic syndromes Iron chelation therapy in myelodysplastic syndromes: where do we stand?Current therapy of myelodysplastic syndromes There's risk, and then there's risk: The latest clinical prognostic risk stratification models in myelodysplastic syndromes.Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IP Myelodysplastic syndromes: toward a risk-adapted treatment approach.The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes.Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome.Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic Syndromes.

P2860

Q26827079-F6276C26-D42A-4B5E-AF62-16DACB11FD5F Q27011747-2BF078F0-4514-42B8-BAEE-D4C2081DE621 Q34013796-02C1C8FD-EE4F-4846-ADBB-5EC1EB3B6AD9 Q34049017-915C7CAA-1875-4A7B-8BC2-7B4578998CC7 Q34783754-0EFBBD6C-0FEB-4FFC-A755-59DCBBEA1860 Q34986462-FA9B3C86-470D-497A-BA94-C450F924398D Q38149315-D9EE0EBB-264B-4F8D-8B15-CD23939D7755 Q38570399-1FB14550-7EF0-40F2-A567-66BC111A5AE0 Q38758162-61146944-CDD7-46C6-AA0D-EA84CE6275D7 Q47305045-9B209539-E60E-4740-AA87-AD2C285735FF Q55311600-FB84DE3F-1F33-4787-9D34-A5F6095DEF5C

P2860

Myelodysplastic syndromes: what do hospitalists need to know?

http://www.wikidata.org/entity/Q27011372

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Myelodysplastic syndromes: what do hospitalists need to know?

@ast

Myelodysplastic syndromes: what do hospitalists need to know?

@en

Myelodysplastic syndromes: what do hospitalists need to know?

@nl

type

label

Myelodysplastic syndromes: what do hospitalists need to know?

@ast

Myelodysplastic syndromes: what do hospitalists need to know?

@en

Myelodysplastic syndromes: what do hospitalists need to know?

@nl

prefLabel

Myelodysplastic syndromes: what do hospitalists need to know?

@ast

Myelodysplastic syndromes: what do hospitalists need to know?

@en

Myelodysplastic syndromes: what do hospitalists need to know?

@nl

P1433

Q27011372-AD96CA70-0373-4508-8B12-F103D9F28B80

P1476

Q27011372-2CB211E1-61B4-4B7A-BA89-B3A8D4F439B0

P2093

Q27011372-4346F69A-CCA2-4288-8E45-7B36E5E50C96

Q27011372-E6F03651-287E-4F82-B623-895E4CDFA627

Q27011372-F06A03CC-7D67-4313-BCB8-6D0A7CFD7E4D

P2860

Q27011372-1174D5C1-6CB0-472F-82CD-4914EF434FD7

Q27011372-12039735-0C0E-4645-BD9B-18BA6FDF8E5E

Q27011372-15F43E20-0FBC-4261-9315-3F23E06AD521

Q27011372-1A6BA438-D53A-4D0D-8245-9AC03390F401

Q27011372-1EFC659F-886B-4002-ACB1-1F53D371A011

Q27011372-2D63CEBE-8FD6-4199-A38B-A6E367454BD6

Q27011372-391D44E9-CAF6-470D-887A-F6A1DAA9B41E

Q27011372-3B98A546-F506-4EA7-A474-0B05CC82B1C4

Q27011372-3C8F8EDB-6184-40F6-9A5D-1107E089AC96

Q27011372-42665231-DE68-4BB6-A977-42A0AE122AB8

P304

Q27011372-7DC189DD-2CFB-46B3-AA85-334E7F8C1DF0

P31

Q27011372-85955B43-97FA-4E86-9F74-6BFB9CA7D4EF

P356

Q27011372-A62044C5-AF15-48E8-B072-A32ADF8F7DDB

P407

Q27011372-651FC28E-CCD4-42F4-B7BC-C67F211D7779

P433

Q27011372-88FECB4D-9E0A-42B8-9FEB-E42064A3DA70

P478

Q27011372-EFD9D251-A613-4E57-B9C1-A4A041CDACE0

P50

Q27011372-9616214D-C670-41B2-99E0-EC19ED6ADE3B

P577

Q27011372-80E442CA-F869-4553-9687-0ED317AD9594

P698

Q27011372-FB11028D-6199-4D7C-AAC2-7412444F3ACD

P932

Q27011372-5C4BEB61-07AF-4959-83EE-47011EAE7A96

P356

P1433

Journal of Hospital Medicine

P1476

Myelodysplastic syndromes: what do hospitalists need to know?

@en

P2093

Amer M Zeidan

http://www.w3.org/2001/XMLSchema#string

B Douglas Smith

http://www.w3.org/2001/XMLSchema#string

Steven Gore

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Epidemiology of myelodysplastic syndromes

Proposals for the classification of the myelodysplastic syndromes

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

International scoring system for evaluating prognosis in myelodysplastic syndromes

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

P304

351-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JHM.2049

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23666619

http://www.w3.org/2001/XMLSchema#string

P932

4234094

http://www.w3.org/2001/XMLSchema#string